Results 111 to 120 of about 110,927 (303)

Mechanism for the Degradation of Erythromycin A and Erythromycin A 2‘-Ethyl Succinate in Acidic Aqueous Solution

, 2016
A major drawback of the antibiotic erythromycin A is its extreme acid sensitivity, leading to rapid inactivation in the stomach. The accepted model for degradation in aqueous acidic solution has erythromycin A in equilibrium with erythromycin A enol ...
Abdolreza Hassanzadeh (2473027), Gareth A. Morris (1333929), Jill Barber (1520668), Peter A. Gorry (2473024)   +3 more
core   +1 more source

Oral Health Care Services, Barriers and Enablers to Maintaining Good Oral Health in Motor Neurone Disease: A Scoping Review

Community Dentistry and Oral Epidemiology, EarlyView.
ABSTRACT Objectives The objective of this scoping review was to map existing literature on oral health and related care in individuals with Motor Neurone Disease (MND). Specifically, the review aimed to identify barriers and facilitators to maintaining oral hygiene, summarise available clinical guidelines and patient‐facing resources, and examine how ...
Mariam A. Khokhar, Lucy A. O'Malley, Anne‐Marie Glenny, Xiaohui Chen   +3 more
wiley   +1 more source

Physicochemical and biological studies of a new erythromycin derivate - erythromycin folate [PDF]

, 2004
Se preparó un derivado nuevo de la eritromicina, el folato de eritromicina, y se evaluaron sus propiedades fisicoquímicas y biológicas. El derivado presenta una buena solubilidad en metanol, etanol y propileno glicol. Los valores de los coeficientes de
Manna, P.K., KUMARAN, V, MANNA, PK, Kumaran, V., Mohanta, G.P., MOHANTA, GP   +5 more
core  

European S2k guidelines on management of autoimmune blistering diseases in children and adolescents

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Autoimmune blistering disorders (AIBDs) in children are rare, challenging to diagnose and treat and often require immunosuppressants. Until now, no paediatric care guidelines existed. The EADV Task Force for AIBDs has developed the consensus‐based recommendations, enabling physicians to adopt a uniform, tailored treatment strategy to improve outcomes ...
A. Nanda, B. Tedbirt, C. Bodemer, M. C. Bolling, M. El Hachem, M. Nikolić, E. Benton, M. Caproni, D. De, D. Didona, K. Drenovska, M. Goebeler, M. Hertl, B. Horváth, M. Kasperkiewicz, D. Kiritsi, M. Larralde, A. V. Marzano, J. Meijer, D. F. Murrell, J. Powell, E. Sprecher, N. S. Chandran, M. M. Tomayko, S. Uzun, N. van Beek, H. Ott, A. Patsatsi, A. Torrelo, A. Welfringer‐Morin, E. Schmidt, P. Joly   +31 more
wiley   +1 more source

Case series of Pityriasis lichenoides in the post-COVID era: Clinical features and response to erythromycin monotherapy [PDF]

Journal of Krishna Institute of Medical Sciences University
Pityriasis Lichenoides (PL) is a rare dermatological condition marked by erythematous papules and plaques, presenting in acute and chronic forms. The COVID-19 pandemic has seen a surge in PL cases, potentially linked to post-viral immune dysregulation ...
Eddula Venkata Ravikanth, Chinni Sai Sahithi, C Sravana Deepthi, M Arun Kumar, Sirshendu Chaudhuri, K H Sneha   +5 more
doaj  

Update of the EuroGuiDerm evidence‐based guideline for the treatment of acne—Short version

Journal of the European Academy of Dermatology and Venereology, EarlyView.
The 2025 EuroGuiDerm guideline update provides evidence‐based recommendations for acne management, addressing systemic antibiotics, systemic isotretinoin, hormonal therapies including spironolactone and contraceptives, and new topical agents. Key considerations include treatment duration, safety, pregnancy‐specific guidance and minimizing antibiotic ...
Alexander Nast, Bassel H. Al Wattar, Marie Beylot Barry, Holger Brüggemann, Zrinka Bukvić Mokos, Dawn M. Caruana, Klaus Degitz, Clio Dessinioti, Brigitte Dréno, Rieke J. B. Driessen, Harald Gollnick, Merete Hædersdal, Alexander Katoulis, Severin Läuchli, Julien Lambert, Alison M. Layton, Giuseppe Micali, Falk R. Ochsendorf, Thozhukat Sathyapalan, Katarina Zak Stangeland, Simon Francis Thomsen, Daniel Töröcsik, Antonia Pennitz   +22 more
wiley   +1 more source

Fixed drug eruption to erythromycin

, 1984
A case of repeated eruption after administration of erythromycin is described.
Pigatto, P, Riva, F, Riboldi, A, Altomare, G F   +3 more
core  

Fate of Erythromycin in Sediment-Containing Surface Water Microcosms: How Does Aged Erythromycin in Sediment Influence Bioavailability?

, 2013
The detection of antibiotics in water and sediment systems is of concern due to the potential adverse effects which could be associated with their environmental fate.
Jessick, Ashley, Coats, Joel, Ashley M. Jessick, Thomas B. Moorman, Joel R. Coats, Moorman, Thomas   +5 more
core   +1 more source

Vectors and Vector‐Borne Diseases: Biology, Epidemiology and Integrated Control Strategies

Journal of Applied Entomology, EarlyView.
ABSTRACT Vector‐Borne Diseases (VBDs), transmitted by arthropods such as mosquitoes, ticks, fleas and sandflies, represent a significant threat to global health. These diseases can be caused by a variety of pathogens, including bacteria, viruses, protozoa, and helminths.
Roberta Rinaldi, Carmen Scieuzo, Federica De Stefano, Luca Masucci, Patrizia Falabella   +4 more
wiley   +1 more source

Erythromycin: safety issues [PDF]

Клиническая микробиология и антимикробная химиотерапия, 2018
Macrolide antimicrobials are widely used for the treatment of variety of community-acquired bacterial infections. This paper is aimed to review the data on the safety issues of erythromycin.
Matveev A.V., Krasheninnikov A.E., Egorova E.A.   +2 more
doaj